This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cota, J. M.
Right arrow Articles by Wiederhold, N. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cota, J. M.
Right arrow Articles by Wiederhold, N. P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2008, p. 1144-1146, Vol. 52, No. 3
0066-4804/08/$08.00+0     doi:10.1128/AAC.01542-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Increases in SLT2 Expression and Chitin Content Are Associated with Incomplete Killing of Candida glabrata by Caspofungin{triangledown}

Jason M. Cota,1,2 Jodi L. Grabinski,1,2 Robert L. Talbert,1,2 David S. Burgess,1,2 P. David Rogers,3 Thomas D. Edlind,4 and Nathan P. Wiederhold1,2*

The University of Texas at Austin College of Pharmacy, Austin, Texas,1 The University of Texas Health Science Center at San Antonio, San Antonio, Texas,2 The University of Tennessee College of Pharmacy, Memphis, Tennessee,3 Drexel University College of Medicine, Philadelphia, Pennsylvania4

Received 29 November 2007/ Accepted 8 December 2007


arrow
ABSTRACT
 
Incomplete killing was observed for caspofungin against Candida glabrata, which was associated with increased SLT2 expression and elevated chitin content. In contrast, fungicidal activity and no chitin increase were observed in an isogenic {Delta}slt2 strain, suggesting a role for SLT2 and chitin production in the response of C. glabrata to caspofungin.


arrow
TEXT
 
Up-regulation of the cell wall integrity (CWI) pathway in Candida albicans upon damage to the cell wall and increases in chitin have correlated with the paradoxical attenuation of caspofungin activity at clinically relevant supra-MIC concentrations (21, 22). Although this effect has not been observed in Candida glabrata (4, 20), studies have reported incomplete killing against some isolates (2, 3, 5, 23). In Saccharomyces cerevisiae, SLT2 encodes a mitogen-activated protein kinase of the CWI pathway that confers protection from damage to the cell wall. An SLT2 homolog has been identified in the C. glabrata genome sequence (http://cbi.labri.fr/Genolevures/index.php). Our objective was to evaluate the potential role of SLT2 and increases in chitin content in the escape of C. glabrata from the fungicidal activity of caspofungin.

A C. glabrata {Delta}slt2 strain and its isogenic parent, C. glabrata 200989, were used in all experiments (7). Stock solutions of caspofungin acetate (Merck & Co., Inc., Whitehouse, NJ) were prepared in sterile distilled water and further diluted in RPMI broth buffered with 0.165 M morpholinepropanesulfonic acid (pH 7). The 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) colorimetric assay was conducted at caspofungin concentrations from 0 to 32 µg/ml as previously described (6, 13). The absorbance was read at 492 nm, and readings were converted to percent absorbance with the growth control set at 100% and medium controls at 0%. Time-kill studies were performed using previously reported methods with caspofungin concentrations of 0, 0.125, 1.0, and 16.0 µg/ml (9). Fungicidal activity was defined as a ≥3-log10 (99.9%) reduction in CFU/ml from the starting inoculum (9).

For gene expression and chitin assays, strains were adjusted to a starting inoculum of ~1 x 104 cells/ml and incubated at 37°C with shaking to ~1 x 106 cells/ml. Cells were then exposed to caspofungin (0, 0.125, 1.0, and 16.0 µg/ml) for 10 min, 180 min, or 12 h. Cells were then harvested, and total RNA was extracted using MasterPure RNA Purification kits (Epicenter Biotechnologies, Madison, WI). Reverse transcription to cDNA was performed (GeneAmp RNA PCR kit, Applied Biosystems, Inc., Foster City, CA), and relative gene expression was determined by real-time PCR (ABI PRISM 7300 sequence detection system), with primers and probes specific for DNA carrying SLT2 and CHS3 as identified within the C. glabrata genome sequence database (Table 1). Relative gene expression levels were calculated by the 2–{Delta}{Delta}CT method using ACT1 as the housekeeping gene (10). For chitin analysis, cells were exposed to caspofungin (0, 0.125, 1.0, and 16.0 µg/ml) for 12 h, cells were harvested, and chitin content was measured as previously described (18). Chitin content was corrected for pellet weight and expressed as changes from control levels. Each study was conducted in triplicate, and differences in fungal viability, CFU, chitin content, and gene expression were compared using one-way analysis of variance (ANOVA) with Tukey's posttest for multiple comparisons.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Primer and Taqman probe sequences used to measure gene expression by real-time PCRa

Complete growth inhibition did not occur at any caspofungin concentration tested against the parent strain, C. glabrata 200989, as measured by the XTT assay (Fig. 1A). Similarly, by time-kill analysis, fungicidal activity was not achieved at any concentration tested against strain 200989, with a maximum 1.6-log10 CFU/ml reduction (Fig. 1B). In contrast, a 100% reduction in absorbance was observed in the {Delta}slt2 strain at concentrations of ≥0.5 µg/ml, and fungicidal activity was observed at 1 and 16 µg/ml (maximum 4.2-log10 CFU/ml reduction) (Fig. 1C). In addition, caspofungin (0.125 µg/ml) had excellent activity, with a 2.6-log10 reduction in CFU/ml. Increased expression of SLT2 was also observed at each caspofungin concentration versus control expression following 10 min of exposure (>2-fold; P < 0.05), and this was most elevated after 180 min (≥3.8-fold; P < 0.05) (Fig. 2A). However, SLT2 transcription was no longer increased at 12 h.


Figure 1
View larger version (12K):
[in this window]
[in a new window]

  		FIG. 1. (A) In vitro XTT colorimetric assay. Percent absorbance (means ± standard deviations) for the parent C. glabrata strain, ATCC 200989 (•), and the corresponding {Delta}slt2 ({circ}) strain compared to results for the control are plotted on the y axis, and increasing concentrations of caspofungin (0 to 32 µg/ml) are plotted on the x axis. (B and C) Plots of log10 CFU/ml (means ± standard deviations) versus time for the parent C. glabrata strain, ATCC 200989 (B), and the {Delta}slt2 strain (C) at the following caspofungin concentrations: {blacksquare} and {square}, control; {blacktriangleup} and {triangleup}, 0.125 µg/ml; {blacklozenge} and {diamond}, 1.0 µg/ml; • and {circ}, 16.0 µg/ml.


Figure 2
View larger version (13K):
[in this window]
[in a new window]

  		FIG. 2. (A) Relative expression of SLT2 in parent strain C. glabrata ATCC 200989 (means ± standard deviations) following caspofungin exposure for 10 min (dark bars), 180 min (gray bars), or 12 h (white bars). (B) Relative expression of CHS3 in the parent C. glabrata strain, ATCC 200989 (dark bars), or the corresponding {Delta}slt2 strain (gray bars) following caspofungin exposure for 180 min. Expression levels were normalized using ACT1 as the housekeeping gene. (C) Changes in chitin content (means ± standard deviations) compared to control levels in the parent C. glabrata strain, ATCC 200989 (dark bars), and the corresponding {Delta}slt2 strain (gray bars) following exposure to 0.125, 1.0, or 16.0 µg/ml of caspofungin for 12 h.

These phenotypic and genotypic data are consistent with findings in previous reports demonstrating a role of the CWI pathway in the coordination of the response to caspofungin-mediated cell wall damage. A rapid and transient induction of SLT2 transcription in S. cerevisiae following a brief exposure to caspofungin has previously been demonstrated (1, 17), while a 50% decrease in viable cells was observed in strains lacking Slt2p activity compared to the isogenic parent (17). Similarly, increased expression of the C. albicans homolog of SLT2, MKC1, has also been observed at elevated drug concentrations, where a paradoxical attenuation of caspofungin activity occurs, and this paradoxical phenotype was absent in a {Delta}mkc1/{Delta}mkc1 homozygous mutant (22).

We also examined chitin content following a caspofungin challenge. In strain 200989, CHS3 transcript levels increased by >2-fold at each caspofungin concentration after 180 min (P < 0.05) (Fig. 2B), accompanied by a >3.3-fold increase in chitin content versus control levels (P < 0.05) (Fig. 2C). In contrast, CHS3 expression did not significantly increase in the {Delta}slt2 strain, nor was chitin content elevated following caspofungin challenge. These data suggest a link between SLT2 and increased chitin content upon cell wall damage by caspofungin in C. glabrata. The increase in chitin content was not unexpected, as other investigators have also demonstrated significant increases in chitin following exposures to different concentrations of echinocandins (16, 21). A link between the CWI pathway and chitin synthesis has also been described for C. albicans. A recent study reported activation of Mkc1p upon exposure to cell wall damaging agents, resulting in an up-regulation in CHS3 transcription and an increase in cell wall chitin (14). However, with the deletion of MKC1, CHS3 expression and chitin content remained unchanged.

While these data indicate an apparent association between SLT2, chitin content, and the response to caspofungin challenge in C. glabrata, further studies involving additional isolates are warranted. Although the CWI pathway appears to be conserved among fungi, this pathway and chitin synthesis have not been fully described for C. glabrata. Additionally, other potential mechanisms for caspofungin tolerance, including up-regulation of 1,3- and 1,6-β-glucan synthesis, increased export of cell wall components for cell wall repair, and the calcineurin pathway, require further investigation (11, 12, 15, 21, 22, 24). These initial data invite further studies since these may lead to strategies that improve outcomes for patients with invasive candidiasis.


arrow
ACKNOWLEDGMENTS
 
Sponsored in part by grants from the American College of Clinical Pharmacy and the University of Texas at Austin College of Graduate Studies to N.P.W.

J.M.C., J.L.G., R.L.T., D.S.B, P.D.R., and T.D.E. have no conflicts of interest to disclose.

N.P.W. has received research support from Pfizer, Inc., and Schering-Plough.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: University of Texas at Austin College of Pharmacy, UTHSCSA, PERC MSC 6220, 7703 Floyd Curl Drive, San Antonio, TX 78229. Phone: (210) 567-8340. Fax: (210) 567-8328. E-mail: wiederholdn{at}uthscsa.edu Back

{triangledown} Published ahead of print on 17 December 2007. Back


arrow
REFERENCES
 
    1
  1. Agarwal, A. K., P. D. Rogers, S. R. Baerson, M. R. Jacob, K. S. Barker, J. D. Cleary, L. A. Walker, D. G. Nagle, and A. M. Clark. 2003. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J. Biol. Chem. 278:34998-35015.[Abstract/Free Full Text]
    2. 2
  2. Barchiesi, F., E. Spreghini, A. W. Fothergill, D. Arzeni, G. Greganti, D. Giannini, M. G. Rinaldi, and G. Scalise. 2005. Caspofungin in combination with amphotericin B against Candida glabrata. Antimicrob. Agents Chemother. 49:2546-2549.[Abstract/Free Full Text]
    3. 3
  3. Barchiesi, F., E. Spreghini, S. Tomassetti, D. Arzeni, D. Giannini, and G. Scalise. 2005. Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata. Antimicrob. Agents Chemother. 49:4989-4992.[Abstract/Free Full Text]
    4. 4
  4. Chamilos, G., R. E. Lewis, N. Albert, and D. P. Kontoyiannis. 2007. Paradoxical effect of echinocandins across Candida species in vitro: evidence for echinocandin-specific and Candida species-related differences. Antimicrob. Agents Chemother. 51:2257-2259.[Abstract/Free Full Text]
    5. 5
  5. Clancy, C. J., H. Huang, S. Cheng, H. Derendorf, and M. H. Nguyen. 2006. Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments. Antimicrob. Agents Chemother. 50:2569-2572.[Abstract/Free Full Text]
    6. 6
  6. Cota, J., M. Carden, J. R. Graybill, L. K. Najvar, D. S. Burgess, and N. P. Wiederhold. 2006. In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility. Antimicrob. Agents Chemother. 50:3926-3928.[Abstract/Free Full Text]
    7. 7
  7. Edlind, T. D., K. W. Henry, J. P. Vermitsky, M. P. Edlind, S. Raj, and S. K. Katiyar. 2005. Promoter-dependent disruption of genes: simple, rapid, and specific PCR-based method with application to three different yeast. Curr. Genet. 48:117-125.[CrossRef][Medline]
    8. 8
  8. Heinisch, J. J., A. Lorberg, H. P. Schmitz, and J. J. Jacoby. 1999. The protein kinase C-mediated MAP kinase pathway involved in the maintenance of cellular integrity in Saccharomyces cerevisiae. Mol. Microbiol. 32:671-680.[CrossRef][Medline]
    9. 9
  9. Klepser, M. E., E. J. Ernst, R. E. Lewis, M. E. Ernst, and M. A. Pfaller. 1998. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob. Agents Chemother. 42:1207-1212.[Abstract/Free Full Text]
    10. 10
  10. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.[CrossRef][Medline]
    11. 11
  11. Markovich, S., A. Yekutiel, I. Shalit, Y. Shadkchan, and N. Osherov. 2004. Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 48:3871-3876.[Abstract/Free Full Text]
    12. 12
  12. Mazur, P., N. Morin, W. Baginsky, M. el-Sherbeini, J. A. Clemas, J. B. Nielsen, and F. Foor. 1995. Differential expression and function of two homologous subunits of yeast 1,3-β-D-glucan synthase. Mol. Cell. Biol. 15:5671-5681.[Abstract]
    13. 13
  13. Meletiadis, J., J. W. Mouton, J. F. Meis, B. A. Bouman, P. J. Donnelly, and P. E. Verweij. 2001. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis[2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 39:4256-4263.[Abstract/Free Full Text]
    14. 14
  14. Munro, C. A., S. Selvaggini, I. de Bruijn, L. Walker, M. D. Lenardon, B. Gerssen, S. Milne, A. J. Brown, and N. A. Gow. 2007. The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans. Mol. Microbiol. 63:1399-1413.[CrossRef][Medline]
    15. 15
  15. Osherov, N., G. S. May, N. D. Albert, and D. P. Kontoyiannis. 2002. Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 46:2462-2469.[Abstract/Free Full Text]
    16. 16
  16. Pfaller, M., J. Riley, and T. Koerner. 1989. Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans. Eur. J. Clin. Microbiol. Infect. Dis. 8:1067-1070.[CrossRef][Medline]
    17. 17
  17. Reinoso-Martin, C., C. Schuller, M. Schuetzer-Muehlbauer, and K. Kuchler. 2003. The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. Eukaryot. Cell 2:1200-1210.[Abstract/Free Full Text]
    18. 18
  18. Ride, J. P., and R. B. Drysdale. 1972. A rapid method for the chemical estimation of filamentous fungi in plant tissue. Physiol. Plant Pathol. 2:7-15.
    19. 19
  19. Shaw, J. A., P. C. Mol., B. Bowers, S. J. Silverman, M. H. Valdivieso, A. Duran, and E. Cabib. 1991. The function of chitin synthases 2 and 3 in the Saccharomyces cerevisiae cell cycle. J. Cell Biol. 114:111-123.[Abstract/Free Full Text]
    20. 20
  20. Stevens, D. A., M. Espiritu, and R. Parmar. 2004. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob. Agents Chemother. 48:3407-3411.[Abstract/Free Full Text]
    21. 21
  21. Stevens, D. A., M. Ichinomiya, Y. Koshi, and H. Horiuchi. 2006. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin. Antimicrob. Agents Chemother. 50:3160-3161.[Abstract/Free Full Text]
    22. 22
  22. Wiederhold, N. P., D. P. Kontoyiannis, R. A. Prince, and R. E. Lewis. 2005. Attenuation of the activity of caspofungin at high concentrations against Candida albicans: possible role of cell wall integrity and calcineurin pathways. Antimicrob. Agents Chemother. 49:5146-5148.[Abstract/Free Full Text]
    23. 23
  23. Wiederhold, N. P., L. K. Najvar, R. Bocanegra, D. Molina, M. Olivo, and J. R. Graybill. 2007. In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera. Antimicrob. Agents Chemother. 51:1616-1620.[Abstract/Free Full Text]
    24. 24
  24. Zhao, C., U. S. Jung, P. Garrett-Engele, T. Roe, M. S. Cyert, and D. E. Levin. 1998. Temperature-induced expression of yeast FKS2 is under the dual control of protein kinase C and calcineurin. Mol. Cell. Biol. 18:1013-1022.[Abstract/Free Full Text]
    25. 25
  25. Ziman, M., J. S. Chuang, and R. W. Schekman. 1996. Chs1p and Chs3p, two proteins involved in chitin synthesis, populate a compartment of the Saccharomyces cerevisiae endocytic pathway. Mol. Biol. Cell 7:1909-1919.[Abstract]

Antimicrobial Agents and Chemotherapy, March 2008, p. 1144-1146, Vol. 52, No. 3
0066-4804/08/$08.00+0     doi:10.1128/AAC.01542-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Badreddine, I., Lafitte, C., Heux, L., Skandalis, N., Spanou, Z., Martinez, Y., Esquerre-Tugaye, M.-T., Bulone, V., Dumas, B., Bottin, A. (2008). Cell Wall Chitosaccharides Are Essential Components and Exposed Patterns of the Phytopathogenic Oomycete Aphanomyces euteiches. Eukaryot Cell 7: 1980-1993 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cota, J. M.
Right arrow Articles by Wiederhold, N. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cota, J. M.
Right arrow Articles by Wiederhold, N. P.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»